Axio BioPharma

Axio BioPharma is revolutionizing biopharma manufacturing by accelerating development timelines. Our plate-based and small-scale research-grade manufacturing services deliver fast, reliable results designed to meet your unique needs. With a focus on efficiency and precision, we help innovators effectively advance their projects. Discover how we can support your programs: https://lnkd.in/gF_CjC9D Let’s connect and explore how we can accelerate your next breakthrough. #Biopharma #DrugDevelopment #Innovation #CDMO

Our CEO, Justin Byers Byers, is presenting at the 2024 Early Stage Symposium in Madison, Wl, as part of the TCIN Presentations Morning Session! Today, Justin is showcasing how Axio BioPharma is transforming biopharmaceutical manufacturing with our rapid, data-driven solutions that accelerate drug development. This is a fantastic opportunity to connect with fellow innovators and investors, and we're thrilled to share our vision of bringing life-saving therapies to patients faster. Best of luck to all the incredible companies pitching today! #EarlyStageSymposium #Biopharma #Innovation #Healthcare #AxioBioPharma #PitchDay

This Veterans Day, we extend our gratitude to the brave men and women who have served our country. Your courage and dedication protect the freedoms we cherish every day. Thank you for your service. — The Axio BioPharma Team 🇺🇸

We're looking forward to connecting at the #CBCSummit2024.

🚀 Axio BioPharma: Accelerating Your Antibody Programs 🚀 Axio BioPharma is dedicated to accelerating your antibody programs with specialized small-scale manufacturing solutions. Our expert team supports early-stage discovery through reliable, flexible production customized to your specific needs. Ready to advance your antibody projects with accelerated timelines and expert guidance? Let’s connect and see how Axio BioPharma can help you achieve your goals faster. https://lnkd.in/gy4J9YkX #Biopharma #AntibodyProduction #MonoclonalAntibodies #AxioBioPharma #AcceleratingSuccess

🌟 Exciting News! 🌟 Axio BioPharma's CEO, Justin Byers, will be pitching at the 2024 Early Stage Symposium in Madison, hosted by the Wisconsin Technology Council. Join us to hear about our rapid, data-driven approach to biopharmaceutical manufacturing and connect with innovators across the industry. We’re looking forward to sharing Axio's journey and vision with the community—see you there! 📅 November 13-14 🔗 Register here to attend: https://lnkd.in/gnsY7_f4 #AxioBioPharma #EarlyStageSymposium #WisconsinTech #Biopharma #Innovation

Please join us in welcoming David Marshall to the Axio BioPharma team! David brings over 20 years of experience in biopharma, specializing in protein expression, antibody drug conjugates, and vaccine production. David’s expertise strengthens our commitment to faster, data-driven protein manufacturing. Welcome to the team David! #WelcomeToTheTeam #AxioBioPharma #ProteinDevelopment #Biopharma #LifeSciences #AntibodyManufacturing

We are pleased to announce that Dr. Greg Bleck and Dr. Graham Brearley have joined Axio BioPharma's Advisory Board. Dr. Greg Bleck, who recently retired as Vice President of R&D at Catalent Biologics, is a biotech innovator with over 30 years of experience. He co-founded Gala Design, which evolved into Gala Biotech and was eventually integrated into Catalent. Throughout his career, Greg has led early development on over 175 molecules currently in clinical trials and invented multiple technologies utilized in biopharmaceutical production. His expertise will be instrumental in guiding our journey forward. Dr. Graham Brearley brings over 30 years of experience in biologics process development, manufacturing operations, and business leadership. Most recently, he served as General Manager and Head of Strategic Ventures at Catalent. He has managed major biologics facilities across the US and EU, overseeing expansions, acquisitions, and divestitures. Graham’s strategic insight will be invaluable to our growth. We look forward to their contributions as we accelerate the development of life-saving therapies. #biopharma #advisoryboard #leadership #innovation #AxioBioPharma

We are thrilled to welcome Jaclyn Mabry to the Axio BioPharma team! With her strong background in protein development and manufacturing, we're excited about the expertise she'll bring to our innovative projects. Join us in giving Jaclyn a warm welcome! #WelcomeToTheTeam #AxioBioPharma #ProteinDevelopment #Biopharma #LifeSciences #NewTeamMember

Ready to take the next step in your research? Axio BioPharma offers small-scale antibody manufacturing. Our approach is specifically designed to support early-stage discovery programs, helping you move quickly and cost-effectively from concept to impactful results. Want to learn more? Contact us today: https://lnkd.in/gz3QgttK #Biopharma #Antibody #mAb #RecombinantProteins #AxioBioPharma #AcceleratingInnovation